Jill K. Bjarke
Bergen, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Cytokine changes during a 12-month pragmatic randomized trial in schizophrenia spectrum disorders comparing amisulpride, aripiprazole and olanzapine.
Journal: Psychiatry research
Published: December 23, 2025
Predicting the path to guided ICBT success across referral pathway for moderate depression and anxiety disorders.
Journal: Internet interventions
Published: September 10, 2025
A pre-treatment comparison of referral pathways to guided ICBT for depression and anxiety disorders - A naturalistic study in routine clinical care.
Journal: Frontiers in digital health
Published: May 22, 2025
Prednisolone add-on in early phase schizophrenia: A randomized, double-blind, placebo-controlled pilot study.
Journal: Brain, behavior, & immunity - health
Published: January 27, 2025
Effectiveness of General Practitioner Referral Versus Self-Referral Pathways to Guided Internet-Delivered Cognitive Behavioral Therapy for Depression, Panic Disorder, and Social Anxiety Disorder: Naturalistic Study.
Journal: JMIR mental health
Published: November 01, 2024
Akathisia and atypical antipsychotics: relation to suicidality, agitation and depression in a clinical trial.
Journal: Acta neuropsychiatrica
Published: March 09, 2022
Different response patterns in hallucinations and delusions to antipsychotic treatment.
Journal: Nordic journal of psychiatry
Published: April 04, 2020
Amisulpride, aripiprazole, and olanzapine in patients with schizophrenia-spectrum disorders (BeSt InTro): a pragmatic, rater-blind, semi-randomised trial.
Journal: The lancet. Psychiatry
Published: February 09, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026